Delivery Order SPE2DB24D8001-SPE2DB25FKZUU

Award Date 6/5/25
Potential Completion Date 6/6/25
Potential Value $1.6K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Anoka, MN, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical division to Dakota Drug, Inc., a self-certified small disadvantaged business. The $1,608.64 contract is for the delivery of TRULICITY 1.5 MG/0.5 ML PEN 0.5ML, a pharmaceutical product, with a performance period ending on June 6, 2024. Dakota Drug, Inc. holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA as part of the ECAT Generation V Program, which allows...
This is a firm fixed-price delivery order worth $1,190.54 awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract is for the delivery of TRULICITY 1.5 MG/0.5 ML PEN 0.5ML, a pharmaceutical medication, with a performance period through November 6, 2024. Dakota Drug, Inc. holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical's ECAT Generation V Program, valued at $999,999,999.00, that allows...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business located in Anoka, Minnesota. The $1,650.43 contract is for the delivery of TRULICITY 1.5 MG/0.5 ML PEN 0.5ML, a diabetes medication, with a completion date of May 23, 2025. Dakota Drug, Inc. holds a significant single-award Indefinite Delivery Contract (IDC) valued at $999,999,999.00 with the DLA as part of the ECAT Generation V Program,...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract, valued at $2,274.39, is for the delivery of TRULICITY 1.5 MG/0.5 ML PEN 0.5ML pharmaceutical products to support U.S. Armed Forces medical operations. The contract is part of the DLA Troop Support Medical's ECAT Generation V Program, a larger indefinite delivery contract (IDC) vehicle awarded to Dakota Drug, Inc....
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract, valued at $3,392.45, is for the delivery of TRULICITY 1.5 MG/0.5 ML PEN 0.5ML, a pharmaceutical product, with a performance period ending on January 8, 2025. Dakota Drug, Inc. is a key supplier for the DLA's Troop Support Medical division, providing a range of pharmaceutical and medical products to support U.S. Armed Forces...
The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract valued at $1,378.16 to Dakota Drug, Inc., a self-certified small disadvantaged business, for the delivery of TRULICITY 3 MG/0.5 ML PEN 0.5ML pharmaceutical products. This order is part of Dakota Drug, Inc.'s larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical division under the ECAT Generation V Program, which has a potential value of $999,999,999.00 and a performance period...
The U.S. Defense Logistics Agency (DLA) awarded a Firm Fixed Price delivery order contract worth $1,312.08 to Dakota Drug, Inc., a self-certified small disadvantaged business, for the delivery of TRULICITY 4.5 MG/0.5 ML PEN 0.5ML. This delivery order is part of Dakota Drug, Inc.'s larger Indefinite Delivery Contract (IDC) worth $999,999,999.00 with the DLA Troop Support Medical under the ECAT Generation V Program, which allows the company to provide a wide range of pharmaceutical products,...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract, valued at $1,065.71, is for the delivery of TRULICITY 1.5 MG/0.5 ML PEN 0.5ML, a pharmaceutical product. The contract has an ultimate completion date of March 31, 2025. This contract award is part of the DLA Troop Support Medical's ECAT Generation V Program, a larger indefinite delivery contract (IDC) valued at...
The Defense Logistics Agency (DLA) awarded a $1,340.67 firm fixed-price delivery order contract to Dakota Drug, Inc., a self-certified small disadvantaged business, for the provision of TRULICITY 1.5 MG/0.5 ML PEN 0.5ML pharmaceutical products. This delivery order is part of a larger $999,999,999.00 single-award Indefinite Delivery Contract (IDC) held by Dakota Drug, Inc. under the DLA Troop Support Medical's ECAT Generation V Program, which procures commercial medical equipment, accessories,...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business, for the delivery of TRULICITY 1.5 MG/0.5 ML PEN 0.5ML pharmaceutical products. The contract has a period of performance through January 24, 2025 and a ceiling value of $2,585.80. This delivery order is part of Dakota Drug, Inc.'s larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical's ECAT Generation V...
  • SPE2DB24D8001
    Indefinite Delivery Contract
  • SPE2DB24D8001-SPE2DB25FKZUU
    Delivery Order

This is a firm-fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business located in Anoka, Minnesota. The contract, valued at $1,560.54, is for the delivery of TRULICITY 1.5 MG/0.5 ML PEN 0.5ML, a pharmaceutical product.

The contract is not set aside and is part of DLA Troop Support Medical's ECAT Generation V Program, which seeks proposals for commercial medical equipment, accessories, consumables, and medical simulation equipment used by medical professionals. Dakota Drug, Inc. holds a significant single-award Indefinite Delivery Contract (IDC) with the DLA, valued at $999,999,999.00, that allows the company to provide a comprehensive range of pharmaceutical products, medical supplies, and healthcare equipment to support U.S. Armed Forces medical operations.

Generated 9/4/25, 9:48 AM